- Home
- CLDT vs INBX Comparison
CLDT vs INBX Comparison
Compare CLDT & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- INBX
- Stock Information
- Founded
- CLDT 2009
- INBX 2010
- Country
- CLDT United States
- INBX United States
- Employees
- CLDT N/A
- INBX N/A
- Industry
- CLDT Real Estate Investment Trusts
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- INBX Health Care
- Exchange
- CLDT Nasdaq
- INBX Nasdaq
- Market Cap
- CLDT 374.7M
- INBX 345.8M
- IPO Year
- CLDT 2010
- INBX 2020
- Fundamental
- Price
- CLDT $7.09
- INBX $26.57
- Analyst Decision
- CLDT Strong Buy
- INBX Hold
- Analyst Count
- CLDT 2
- INBX 2
- Target Price
- CLDT $10.75
- INBX N/A
- AVG Volume (30 Days)
- CLDT 271.2K
- INBX 112.9K
- Earning Date
- CLDT 11-06-2025
- INBX 11-13-2025
- Dividend Yield
- CLDT 5.20%
- INBX N/A
- EPS Growth
- CLDT N/A
- INBX N/A
- EPS
- CLDT 0.03
- INBX N/A
- Revenue
- CLDT $310,140,000.00
- INBX $1,400,000.00
- Revenue This Year
- CLDT N/A
- INBX N/A
- Revenue Next Year
- CLDT $0.58
- INBX N/A
- P/E Ratio
- CLDT $252.00
- INBX N/A
- Revenue Growth
- CLDT N/A
- INBX N/A
- 52 Week Low
- CLDT $5.83
- INBX $10.81
- 52 Week High
- CLDT $10.00
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- CLDT 44.70
- INBX 53.24
- Support Level
- CLDT $7.07
- INBX $26.19
- Resistance Level
- CLDT $7.11
- INBX $28.86
- Average True Range (ATR)
- CLDT 0.15
- INBX 1.35
- MACD
- CLDT -0.06
- INBX -0.40
- Stochastic Oscillator
- CLDT 26.83
- INBX 11.14
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.